Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 5
2005 4
2006 1
2007 2
2008 7
2009 12
2010 13
2011 22
2012 21
2013 13
2014 20
2015 15
2016 9
2017 3
2018 2
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

133 results
Results by year
Filters applied: . Clear all
Page 1
AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer.
Cross DA, Ashton SE, Ghiorghiu S, Eberlein C, Nebhan CA, Spitzler PJ, Orme JP, Finlay MR, Ward RA, Mellor MJ, Hughes G, Rahi A, Jacobs VN, Red Brewer M, Ichihara E, Sun J, Jin H, Ballard P, Al-Kadhimi K, Rowlinson R, Klinowska T, Richmond GH, Cantarini M, Kim DW, Ranson MR, Pao W. Cross DA, et al. Cancer Discov. 2014 Sep;4(9):1046-61. doi: 10.1158/2159-8290.CD-14-0337. Epub 2014 Jun 3. Cancer Discov. 2014. PMID: 24893891 Free PMC article.
Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer.
Pao W, Chmielecki J. Pao W, et al. Nat Rev Cancer. 2010 Nov;10(11):760-74. doi: 10.1038/nrc2947. Epub 2010 Oct 22. Nat Rev Cancer. 2010. PMID: 20966921 Free PMC article. Review.
Computational properties of mitochondria in T cell activation and fate.
Uzhachenko R, Shanker A, Dupont G. Uzhachenko R, et al. Open Biol. 2016 Nov;6(11):160192. doi: 10.1098/rsob.160192. Open Biol. 2016. PMID: 27852805 Free PMC article. Review.
Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models.
Eberlein CA, Stetson D, Markovets AA, Al-Kadhimi KJ, Lai Z, Fisher PR, Meador CB, Spitzler P, Ichihara E, Ross SJ, Ahdesmaki MJ, Ahmed A, Ratcliffe LE, O'Brien EL, Barnes CH, Brown H, Smith PD, Dry JR, Beran G, Thress KS, Dougherty B, Pao W, Cross DA. Eberlein CA, et al. Cancer Res. 2015 Jun 15;75(12):2489-500. doi: 10.1158/0008-5472.CAN-14-3167. Epub 2015 Apr 13. Cancer Res. 2015. PMID: 25870145 Free PMC article.
Proteogenomic Analysis of Surgically Resected Lung Adenocarcinoma.
Sharpnack MF, Ranbaduge N, Srivastava A, Cerciello F, Codreanu SG, Liebler DC, Mascaux C, Miles WO, Morris R, McDermott JE, Sharpnack JL, Amann J, Maher CA, Machiraju R, Wysocki VH, Govindan R, Mallick P, Coombes KR, Huang K, Carbone DP. Sharpnack MF, et al. J Thorac Oncol. 2018 Oct;13(10):1519-1529. doi: 10.1016/j.jtho.2018.06.025. Epub 2018 Jul 11. J Thorac Oncol. 2018. PMID: 30017829 Free PMC article.
Modulatory effects of bortezomib on host immune cell functions.
Pellom ST Jr, Dudimah DF, Thounaojam MC, Sayers TJ, Shanker A. Pellom ST Jr, et al. Immunotherapy. 2015;7(9):1011-22. doi: 10.2217/imt.15.66. Epub 2015 Sep 1. Immunotherapy. 2015. PMID: 26325610 Free PMC article. Review.
Challenges and future perspectives of T cell immunotherapy in cancer.
de Aquino MT, Malhotra A, Mishra MK, Shanker A. de Aquino MT, et al. Immunol Lett. 2015 Aug;166(2):117-33. doi: 10.1016/j.imlet.2015.05.018. Epub 2015 Jun 19. Immunol Lett. 2015. PMID: 26096822 Free PMC article. Review.
Common gamma chain cytokines in combinatorial immune strategies against cancer.
Pulliam SR, Uzhachenko RV, Adunyah SE, Shanker A. Pulliam SR, et al. Immunol Lett. 2016 Jan;169:61-72. doi: 10.1016/j.imlet.2015.11.007. Epub 2015 Nov 17. Immunol Lett. 2016. PMID: 26597610 Free PMC article. Review.
Beyond histology: translating tumor genotypes into clinically effective targeted therapies.
Meador CB, Micheel CM, Levy MA, Lovly CM, Horn L, Warner JL, Johnson DB, Zhao Z, Anderson IA, Sosman JA, Vnencak-Jones CL, Dahlman KB, Pao W. Meador CB, et al. Clin Cancer Res. 2014 May 1;20(9):2264-75. doi: 10.1158/1078-0432.CCR-13-1591. Epub 2014 Mar 5. Clin Cancer Res. 2014. PMID: 24599935 Free PMC article. Review.
Somatostatin receptor 2 signaling promotes growth and tumor survival in small-cell lung cancer.
Lehman JM, Hoeksema MD, Staub J, Qian J, Harris B, Callison JC, Miao J, Shi C, Eisenberg R, Chen H, Chen SC, Massion PP. Lehman JM, et al. Int J Cancer. 2019 Mar 1;144(5):1104-1114. doi: 10.1002/ijc.31771. Epub 2018 Oct 9. Int J Cancer. 2019. PMID: 30152518 Free PMC article.
133 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback